Larvol Delta - A-Multicenter-OpenLabel-NonRandomized-SingleArm-Clinical-Study-of-Nanobody-CD5CAR-T-Cell-Therapy-for-RefractoryRelapsed-T-Lymphocyte-Malignancies

Autologous CD5 CAR T-cells - Beijing GoBroad Hospital

http://clinicaltrials.gov/ct2/show/NCT07070323

Jul 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next